CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (24,400)	$ (18,810)
Less: Net income from discontinued operations, net of tax		3,157
Net loss from continuing operations	(24,400)	(21,967)
Adjustments to reconcile net loss from continuing operations to net cash (used in) provided by operating activities:
Depreciation expense	12,108	13,053
Intangible asset amortization	3,995	4,033
Stock-based compensation	8,186	8,561
Amortization of debt issuance costs and discount	877	7,811
Noncash operating lease cost	2,591	2,680
Revenue assigned to factors	(2,143)	(3,665)
Deferred tax assets, net	132	389
Other	122	209
Changes in operating assets and liabilities of continuing operations:
Accounts receivable	(26,787)	4,192
Inventories	(4,634)	3,034
Prepaid expenses and other assets	(8,878)	403
Accounts payable	20,752	(4,862)
Accrued liabilities	2,802	4,016
Deferred revenue	(2,883)	(10,544)
Operating lease liabilities	(3,681)	(3,635)
Net cash (used in) provided by operating activities - continuing operations	(21,841)	3,708
Net cash used in operating activities - discontinued operations		(395)
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES	(21,841)	3,313
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(9,294)	(10,342)
Net cash used in investing activities - continuing operations	(9,294)	(10,342)
Net cash provided by investing activities - discontinued operations		5,721
NET CASH USED IN INVESTING ACTIVITIES	(9,294)	(4,621)
CASH FLOWS FROM FINANCING ACTIVITIES:
Taxes paid related to net share settlement of vested equity awards	(1,675)	(4,128)
Proceeds from exercise of stock options and contributions to employee stock purchase plan	502	900
NET CASH USED IN FINANCING ACTIVITIES	(1,173)	(3,228)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(2,007)	1,026
Net change in cash and cash equivalents	(34,315)	(3,510)
Cash and cash equivalents at beginning of period	79,221	94,624
Cash and cash equivalents at end of period	$ 44,906	$ 91,114